OOIR: Observatory of International Research

Papers

(The median citation count of Retrovirology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis	43
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection	41
Rotten to the core: antivirals targeting the HIV-1 capsid core	38
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread	30
HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection	27
The HIV-1 capsid and reverse transcription	27
Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection	26
Humanized Mice for Infectious and Neurodegenerative disorders	22
HIV infection of non-classical cells in the brain	22
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules	21
Defective HIV-1 genomes and their potential impact on HIV pathogenesis	19
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure	18
YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity	15
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy	14
Co-receptor signaling in the pathogenesis of neuroHIV	14
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle	12
Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana	12
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency	11
Trim28 acts as restriction factor of prototype foamy virus replication by modulating H3K9me3 marks and destabilizing the viral transactivator Tas	11
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse	10
Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey	10
Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection	9
Pericyte infection by HIV-1: a fatal attraction	9
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells	9
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65	9

Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome	9
Addressing an HIV cure in LMIC	8
No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan	8
Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency	8
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants	8
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features	7
Editing out HIV: application of gene editing technology to achieve functional cure	7
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda	7
HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio	7
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships	6
An ancient retroviral RNA element hidden in mammalian genomes and its involvement in co-opted retroviral gene regulation	6
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection	6
Attenuation of reverse transcriptase facilitates SAMHD1 restriction of HIV-1 in cycling cells	6
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor	5
Origin and functional role of antisense transcription in endogenous and exogenous retroviruses	5
A novel class III endogenous retrovirus with a class I envelope gene in African frogs with an intact genome and developmentally regulated transcripts in Xenopus tropicalis	5
The cell biology of HIV-1 latency and rebound	5
DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence	5
Modulation of human endogenous retroviruses and cytokines expression in peripheral blood mononuclear cells from autistic children and their parents	5
Replication-competent HIV-1 in human alveolar macrophages and monocytes despite nucleotide pools with elevated dUTP	5
An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise	4
HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity	4
A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism	3
Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG	3
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators	3
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization	3
The key amino acid sites 199–205, 269, 319, 321 and 324 of ALV-K env contribute to the weaker replication capacity of ALV-K than ALV-A	3
A novel Betaretrovirus discovered in cattle with neurological disease and encephalitis	3
Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection	3
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control	3
Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core	3
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa	3
Intestinal endothelial cells increase HIV infection and latency in resting and activated CD4 + T cells, particularly affecting CCR6 + CD4 + T cells	3
Innate immune regulation in HIV latency models	3
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models	3
Cocaine augments neuro-inflammation via modulating extracellular vesicle release in HIV-1 infected immune cells	3
An endogenous lentivirus in the germline of a rodent	3
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation	3